Penicillin Skin Testing in Patients With History of Allergic Reactions to Betalactams
Overview
This study aims to compare the readings of skin testing results in patients with suspected penicillin allergy between in-house penicillin test preparation and commercial available penicillin testing kit.
Full Title of Study: “The Comparative Results of Penicillin Testing in Patients With History of Allergic Reactions to Betalactams Between Using In-house Penicillin Test Preparation and Commercial Available Penicillin Testing Kit”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Diagnostic
- Masking: None (Open Label)
- Study Primary Completion Date: March 2010
Detailed Description
The results of skin test with immediate reading will be compared between alkali-treated penicillin G and DAP reagents from Diater
Interventions
- Procedure: Immediate skin test
- Intradermal test with immediate reading
Arms, Groups and Cohorts
- Active Comparator: In-house penicillin testing preparation
- In-house penicillin testing prepared from alkali-treated penicillin G
- Active Comparator: Commercial penicillin test kit
- Commercial penicillin test kit order from Diater company
- Active Comparator: Penicillin G Sodium
- Penicillin G Sodium from routine clinical use
Clinical Trial Outcome Measures
Primary Measures
- The skin testing results of in-house penicillin skin test and Penicillin G Sodium compared to commercial penicillin testing kit
- Time Frame: 1 year
Secondary Measures
- Clinical correlation and side effects
- Time Frame: 1 year
- Correlations between Penicillin skin test result with specific IgE and/or basophil activation test
- Time Frame: 1 year
Participating in This Clinical Trial
Inclusion Criteria
1. Patients with history of hypersensitivity reactions to betalactams; penicillin, aminopenicillins, and cephalosporins 2. 15-65 years of age Exclusion Criteria:
1. On antihistamine/ cannot discontinue antihistamine before the test 2. Having asthma exacerbation 3. Being pregnant 4. Suffering from severe systemic disease/ in bad health
Gender Eligibility: All
Minimum Age: 15 Years
Maximum Age: 65 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Chulalongkorn University
- Collaborator
- Mahidol University
- Provider of Information About this Clinical Study
- Jettanong Klaewsongkram, MD, Chulalongkorn University
- Overall Official(s)
- Jettanong Klaewsongkram, MD, Principal Investigator, Chulalongkorn University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.